MASA syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2466OMIM:303350G11.4
Who is this for?
Show terms as
4Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

MASA syndrome is a rare X-linked neurological disorder whose name is an acronym for its four cardinal features: Mental retardation (intellectual disability), Aphasia (delayed speech), Shuffling gait (spastic paraplegia), and Adducted thumbs. It is caused by mutations in the L1CAM gene located on the X chromosome (Xq28), which encodes the L1 cell adhesion molecule, a protein critical for nervous system development including neuronal migration, axon guidance, and myelination. MASA syndrome is part of a spectrum of L1CAM-associated disorders that also includes X-linked hydrocephalus (HSAS), X-linked complicated hereditary spastic paraplegia type 1 (SPG1), and X-linked agenesis of the corpus callosum. These conditions are collectively referred to as L1 syndrome. The condition primarily affects the central nervous system. Males are predominantly affected, while carrier females are usually asymptomatic or mildly affected. Key clinical features include mild to moderate intellectual disability, delayed speech and language development, lower limb spasticity resulting in a characteristic shuffling gait, and clasped or adducted thumbs due to absence or hypoplasia of the extensor pollicis longus or brevis muscles. Additional features may include hypoplasia or agenesis of the corpus callosum, mild to moderate ventricular enlargement (hydrocephalus), and variable degrees of corticospinal tract dysfunction. Brain MRI may reveal structural abnormalities including corpus callosum anomalies and enlarged ventricles. There is currently no cure for MASA syndrome. Treatment is supportive and multidisciplinary, focusing on managing symptoms and optimizing developmental outcomes. This may include physical therapy and orthopedic interventions for spasticity and gait abnormalities, speech and language therapy, special education services, and occupational therapy. In cases with significant hydrocephalus, neurosurgical intervention such as ventriculoperitoneal shunting may be required. Genetic counseling is important for affected families given the X-linked inheritance pattern.

Also known as:

Clinical phenotype terms— hover any for plain English:

Hand clenchingHP:0001188
Inheritance

X-linked recessive

Carried on the X chromosome; typically affects males more than females

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for MASA syndrome.

View clinical trials →

No actively recruiting trials found for MASA syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the MASA syndrome community →

Specialists

4 foundView all specialists →
JP
José A. Casajús, MD, PhD
Specialist
PI on 1 active trial
MP
Meagan A Jacoby, M.D., Ph.D.
St Louis, Missouri
Specialist

Rare Disease Specialist

PI on 1 active trial
DP
David Beck, MD, PhD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to MASA syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open MASA syndromeForum →

No community posts yet. Be the first to share your experience with MASA syndrome.

Start the conversation →

Latest news about MASA syndrome

No recent news articles for MASA syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about MASA syndrome

What is MASA syndrome?

MASA syndrome is a rare X-linked neurological disorder whose name is an acronym for its four cardinal features: Mental retardation (intellectual disability), Aphasia (delayed speech), Shuffling gait (spastic paraplegia), and Adducted thumbs. It is caused by mutations in the L1CAM gene located on the X chromosome (Xq28), which encodes the L1 cell adhesion molecule, a protein critical for nervous system development including neuronal migration, axon guidance, and myelination. MASA syndrome is part of a spectrum of L1CAM-associated disorders that also includes X-linked hydrocephalus (HSAS), X-lin

How is MASA syndrome inherited?

MASA syndrome follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does MASA syndrome typically begin?

Typical onset of MASA syndrome is neonatal. Age of onset can vary across affected individuals.

Which specialists treat MASA syndrome?

4 specialists and care centers treating MASA syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.